Individualized drug dosage in patients treated with continuous hemofiltration
1Nephrology, University Hospital, Ulm, Germany. frieder.keller@medizin.uni-ulm.de
Kidney International. Supplement
|November 24, 1999
Summary
Individualizing drug dosage for intensive care patients undergoing hemofiltration is crucial. A proposed method uses total creatinine clearance (C(Cr)) to adjust medication, offering a practical alternative to standard dosing schemes.
Area of Science:
- Pharmacokinetics and Pharmacodynamics
- Nephrology
- Critical Care Medicine
Background:
- Subtherapeutic drug dosing poses significant risks, particularly for intensive care unit (ICU) patients undergoing hemofiltration.
- Accurate drug dosing is essential to prevent adverse events and ensure therapeutic efficacy in critically ill patients.
Purpose of the Study:
- To propose a method for individualizing drug dosage in patients undergoing high-flux hemofiltration.
- To evaluate the application of Dettli's fundamental equation using total creatinine clearance for drug dosage adjustments.
Main Methods:
- Utilized Dettli's fundamental equation, which describes drug clearance (Cl) as a linear function of creatinine clearance (C(Cr)).
- Proposed calculating total creatinine clearance (C(Cr) tot) by summing renal (C(Cr) ren) and filtration (C(Cr) filt) components.
- Acknowledged potential overestimation of drug clearance for drugs with significant tubular secretion during high-efficiency hemofiltration (C(Cr) tot > 30 ml/min).
Main Results:
- The proposed method allows for the individualization of drug dosage based on patient-specific total creatinine clearance.
- This approach offers a practical alternative to standardized dosing protocols in hemofiltration settings.
- Potential limitations include overestimation of clearance for certain drug types and filtration efficiencies.
Conclusions:
- The total creatinine clearance approach provides a practical method for individualizing drug dosage in patients undergoing hemofiltration.
- This strategy can be used to derive individualized dosages from existing pharmacokinetic data.
- It represents a viable alternative to conventional dosing schemes in this patient population.
Related Concept Videos
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
01:25Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
01:30Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...